ZA200203178B - New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist. - Google Patents

New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist.

Info

Publication number: ZA200203178B
Authority: ZA; South Africa
Prior art keywords: beta; new combination; adreno; receptor antagonist; receptor agonist
Prior art date: 1999-11-03

Application number

ZA200203178A

Inventor

Jan Trofast

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-03

Filing date

2002-04-22

Publication date

2003-07-22

2002-04-22 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-07-22 Publication of ZA200203178B publication Critical patent/ZA200203178B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

ZA200203178A 1999-11-03 2002-04-22 New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist. ZA200203178B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9903995A SE9903995D0 (en)	1999-11-03	1999-11-03	New combination

Publications (1)

Publication Number	Publication Date
ZA200203178B true ZA200203178B (en)	2003-07-22

Family

ID=20417605

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200203178A ZA200203178B (en)	1999-11-03	2002-04-22	New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist.

Country Status (13)

Country	Link
EP (1)	EP1242065A1 (en)
JP (1)	JP2003513037A (en)
KR (1)	KR20020050254A (en)
CN (1)	CN1387431A (en)
AU (2)	AU1321401A (en)
BR (1)	BR0015172A (en)
CA (1)	CA2388657A1 (en)
IL (1)	IL149365A0 (en)
MX (1)	MXPA02004334A (en)
NO (1)	NO20022103L (en)
SE (1)	SE9903995D0 (en)
WO (2)	WO2001032163A1 (en)
ZA (1)	ZA200203178B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030055026A1 (en)	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en)	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
AR040962A1 (en) *	2002-08-09	2005-04-27	Novartis Ag	COMPOUNDS DERIVED FROM TIAZOL 1,3-2-ONA, PHARMACEUTICAL COMPOSITION AND COMPOSITE PREPARATION PROCESS
GB0312148D0 (en)	2003-05-28	2003-07-02	Aventis Pharma Ltd	Stabilized pharmaceutical products
GB0315889D0 (en)	2003-07-08	2003-08-13	Aventis Pharma Ltd	Stable pharmaceutical products
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
EP1742625A1 (en) *	2004-04-05	2007-01-17	Sepracor, Inc.	(r,r)-formoterol in combination with other pharmacological agents
ES2245612B1 (en) *	2004-06-29	2007-08-16	Universidad De Barcelona	NEW THERAPEUTIC USE OF FORMOTEROL.
CN101128196B (en) *	2005-03-16	2013-01-02	Meda制药有限及两合公司	Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
JP2014518203A (en) *	2011-06-06	2014-07-28	キエスィファルマチェウティチエス．ピー．エー．	1-Phenyl-2-pyridinylalkyl alcohol derivatives as phosphodiesterase inhibitors
TR201907092T4 (en) *	2012-12-05	2019-06-21	Chiesi Farm Spa	1-phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors.
JP5846185B2 (en)	2013-11-21	2016-01-20	大日本印刷株式会社	Through electrode substrate and semiconductor device using the through electrode substrate
PT109030B (en) *	2015-12-15	2019-09-25	Hovione Farmaciência, S.A.	PREPARATION OF ZAFIRLUCAST INHALABLE PARTICULES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9604752D0 (en) *	1996-12-20	1996-12-20	Astra Ab	Formulation and use
ATE317224T1 (en) *	1997-03-13	2006-02-15	Merck & Co Inc	QUINOLINE-LEUKOTRIEN ANTAGONISTS
SE9704644D0 (en) *	1997-12-12	1997-12-12	Astra Ab	New use

1999
- 1999-11-03 SE SE9903995A patent/SE9903995D0/en unknown
2000
- 2000-10-27 AU AU13214/01A patent/AU1321401A/en not_active Abandoned
- 2000-10-27 WO PCT/SE2000/002115 patent/WO2001032163A1/en not_active Application Discontinuation
- 2000-10-27 IL IL14936500A patent/IL149365A0/en unknown
- 2000-10-27 AU AU16526/01A patent/AU1652601A/en not_active Abandoned
- 2000-10-27 BR BR0015172-6A patent/BR0015172A/en not_active Application Discontinuation
- 2000-10-27 CA CA002388657A patent/CA2388657A1/en not_active Abandoned
- 2000-10-27 CN CN00815363A patent/CN1387431A/en active Pending
- 2000-10-27 EP EP00975117A patent/EP1242065A1/en not_active Withdrawn
- 2000-10-27 WO PCT/SE2000/002116 patent/WO2001032166A1/en active Application Filing
- 2000-10-27 JP JP2001534368A patent/JP2003513037A/en active Pending
- 2000-10-27 KR KR1020027005683A patent/KR20020050254A/en not_active Application Discontinuation
- 2000-10-27 MX MXPA02004334A patent/MXPA02004334A/en unknown
2002
- 2002-04-22 ZA ZA200203178A patent/ZA200203178B/en unknown
- 2002-05-02 NO NO20022103A patent/NO20022103L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2001032163A1 (en)	2001-05-10
BR0015172A (en)	2002-06-18
AU1321401A (en)	2001-05-14
MXPA02004334A (en)	2002-11-07
KR20020050254A (en)	2002-06-26
AU1652601A (en)	2001-05-14
NO20022103D0 (en)	2002-05-02
CA2388657A1 (en)	2001-05-10
EP1242065A1 (en)	2002-09-25
JP2003513037A (en)	2003-04-08
SE9903995D0 (en)	1999-11-03
CN1387431A (en)	2002-12-25
IL149365A0 (en)	2002-11-10
WO2001032166A1 (en)	2001-05-10
NO20022103L (en)	2002-05-02

Publication	Publication Date	Title
HUP0101411A3 (en)	2002-11-28	A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof
AP2000001916A0 (en)	2000-09-30	2-Adrenergic receptor agonists
ZA985678B (en)	2000-01-10	1-amino-alkylcyclohexane NMDA receptor antagonists.
IL139913A0 (en)	2002-02-10	Neuropeptide y5 receptor antagonists
EP1105389A4 (en)	2001-10-17	Integrin receptor antagonists
ZA200203178B (en)	2003-07-22	New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist.
ZA200100978B (en)	2002-02-05	Muscarinic agonists and antagonists.
EP1061921A4 (en)	2005-03-30	Vitronectin receptor antagonists
IL137930A0 (en)	2001-10-31	Benzylpiperazinyl and benzylpiperidinyl ethanone derivatives, their preparation and their use as a dopamine d4 receptor antagonists
HK1042037A1 (en)	2002-08-02	Vitronectin receptor antagonist.
AU5861900A (en)	2001-01-02	Receptor agonists and antagonists
AU6230698A (en)	1998-09-18	Dopamine d4 receptor antagonist
ZA200301162B (en)	2004-05-12	Gem-substituted alpha V beta 3 integrin antagonists.
ZA995029B (en)	2001-02-05	Estrogen agonists/antagonists.
PL351546A1 (en)	2003-05-05	1,5−benzodiazepine derivatives as cck−a receptor agonists
HK1048803B (en)	2004-01-30	β 2-ADRENERGIC RECEPTOR AGONISTS
SI1235787T1 (en)	2004-04-30	$g(b)2-ADRENERGIC RECEPTOR AGONISTS
ZA200004561B (en)	2001-11-30	β 2-adrenergic receptor agonists.
ZA991884B (en)	1999-09-10	Vitronectin receptor antagonists.
ZA9610690B (en)	1997-10-29	Integrin receptor antagonists.
ZA978798B (en)	1998-04-02	Vitronectin receptor antagonists.
AUPP058597A0 (en)	1997-12-18	Receptor agonists and antagonists
GB9811283D0 (en)	1998-07-22	Vironectin receptor antagonists
SI1019075T1 (en)	2006-02-28	Beta 2-adrenergic receptor agonists
GB9822701D0 (en)	1998-12-09	Intergrin receptor antagonists